TY - JOUR
T1 - MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis
AU - Rebustini, Ivan T
AU - Myers, Christopher
AU - Lassiter, Keyonica S
AU - Surmak, Andrew
AU - Szabova, Ludmila
AU - Holmbeck, Kenn
AU - Pedchenko, Vadim
AU - Hudson, Billy G
AU - Hoffman, Matthew P
PY - 2009/10
Y1 - 2009/10
N2 - Proteolysis is essential during branching morphogenesis, but the roles of MT-MMPs and their proteolytic products are not clearly understood. Here, we discover that decreasing MT-MMP activity during submandibular gland branching morphogenesis decreases proliferation and increases collagen IV and MT-MMP expression. Specifically, reducing epithelial MT2-MMP profoundly decreases proliferation and morphogenesis, increases Col4a2 and intracellular accumulation of collagen IV, and decreases the proteolytic release of collagen IV NC1 domains. Importantly, we demonstrate the presence of collagen IV NC1 domains in developing tissue. Furthermore, recombinant collagen IV NC1 domains rescue branching morphogenesis after MT2-siRNA treatment, increasing MT-MMP and proproliferative gene expression via beta1 integrin and PI3K-AKT signaling. Additionally, HBEGF also rescues MT2-siRNA treatment, increasing NC1 domain release, proliferation, and MT2-MMP and Hbegf expression. Our studies provide mechanistic insight into how MT2-MMP-dependent release of bioactive NC1 domains from collagen IV is critical for integrating collagen IV synthesis and proteolysis with epithelial proliferation during branching morphogenesis.
AB - Proteolysis is essential during branching morphogenesis, but the roles of MT-MMPs and their proteolytic products are not clearly understood. Here, we discover that decreasing MT-MMP activity during submandibular gland branching morphogenesis decreases proliferation and increases collagen IV and MT-MMP expression. Specifically, reducing epithelial MT2-MMP profoundly decreases proliferation and morphogenesis, increases Col4a2 and intracellular accumulation of collagen IV, and decreases the proteolytic release of collagen IV NC1 domains. Importantly, we demonstrate the presence of collagen IV NC1 domains in developing tissue. Furthermore, recombinant collagen IV NC1 domains rescue branching morphogenesis after MT2-siRNA treatment, increasing MT-MMP and proproliferative gene expression via beta1 integrin and PI3K-AKT signaling. Additionally, HBEGF also rescues MT2-siRNA treatment, increasing NC1 domain release, proliferation, and MT2-MMP and Hbegf expression. Our studies provide mechanistic insight into how MT2-MMP-dependent release of bioactive NC1 domains from collagen IV is critical for integrating collagen IV synthesis and proteolysis with epithelial proliferation during branching morphogenesis.
KW - Animals
KW - Blotting, Western
KW - Cell Proliferation
KW - Collagen Type IV/metabolism
KW - Epithelial Cells/metabolism
KW - Fluorescent Antibody Technique
KW - Heparin/metabolism
KW - Heparin-binding EGF-like Growth Factor
KW - Immunoprecipitation
KW - Integrin beta1/genetics
KW - Intercellular Signaling Peptides and Proteins/genetics
KW - Matrix Metalloproteinase 14/physiology
KW - Matrix Metalloproteinase 15/genetics
KW - Matrix Metalloproteinase Inhibitors
KW - Mice
KW - Mice, Knockout
KW - Morphogenesis
KW - Phosphatidylinositol 3-Kinases/genetics
KW - Proto-Oncogene Proteins c-akt/genetics
KW - RNA, Messenger/genetics
KW - RNA, Small Interfering/pharmacology
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Submandibular Gland/growth & development
U2 - 10.1016/j.devcel.2009.07.016
DO - 10.1016/j.devcel.2009.07.016
M3 - Journal article
C2 - 19853562
SN - 1534-5807
VL - 17
SP - 482
EP - 493
JO - Developmental Cell
JF - Developmental Cell
IS - 4
ER -